Publication: Formulary Journal

First reported 8 hours ago - Updated 8 hours ago - 1 reports

Flu vaccine: What you need to know

Dr SchaffnerThe Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices recommends that people aged 6 months and older receive an annual flu vaccine .“There is complete certainty that there will be a flu season,” ... [Published Formulary Journal - 8 hours ago]
First reported Oct 08 2014 - Updated Oct 08 2014 - 1 reports

Bristol-Myers Squibb withdraws potential hep C combo therapy

Bristol-Myers Squibb (BMS) will not pursue FDA approval of its hepatitis C (HCV) treatment, a dual regimen of daclatasvir and asunaprevir, and has withdrawn its new drug application (NDA) for asunaprevir, an NS3/4A protease inhibitor.BMS will continue ... [Published Formulary Journal - Oct 08 2014]
First reported Oct 08 2014 - Updated Oct 08 2014 - 1 reports

Dallas Ebola victim dies; received experimental drug

Responding to requests from treating physicians, FDA has okayed brincidofovir for Emergency Investigational New Drug Applications (EIND), allowing it to be used in the treatment of the Ebola Virus Disease.The drug, developed by biopharmaceutical company ... [Published Formulary Journal - Oct 08 2014]
Entities: Ebola, Ebola Virus, Drugs
First reported Oct 08 2014 - Updated Oct 08 2014 - 1 reports

Specialty drugs: A good value, despite high costs

Dr ChambersSpecialty drugs’ high prices raise questions about whether their cost is worth the clinical benefits they provide, according to a recent study in Health Affairs .Lead author to James D. Chambers, assistant professor of medicine, the Tufts Medical ... [Published Formulary Journal - Oct 08 2014]
First reported Oct 08 2014 - Updated Oct 08 2014 - 1 reports

Metformin linked to low levels of thyroid-stimulating hormone levels in hypothyroidism

Dr FournierLow thyroid stimulating hormone (TSH) can be observed in patients with treated hypothyroidism initiating metformin , especially between 90 and 180 days of use, according to a study published September 22 in the CMJA .Hypothyroidism and type ... [Published Formulary Journal - Oct 08 2014]
First reported Oct 07 2014 - Updated Oct 08 2014 - 1 reports

Cost, use of opioid dependence treatment are increasing, spurring need for care management programs

Understanding the patterns and costs associated with opioid dependence treatments is important when developing and improving care management programs for plan members, according to 2 studies by pharmacy benefit manager Prime Therapeutics LLC (Prime).“This ... [Published Formulary Journal - Oct 07 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 1 reports

Study to measure impact of MTM on outcomes for IBD patients

Dr AndrosThe effectiveness of an inflammatory bowel disease (IBD) medication therapy management (MTM) patient fulfillment model and its impact on adherence compared to standard care will be evaluated in a new study.Curant Health , provider of enhanced ... [Published Formulary Journal - Oct 03 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

FDA: Slightly elevated risk of cardiovascular, cerebrovascular with Xolair

An FDA review of safety studies suggests a slightly increased risk of problems involving the heart and blood vessels supplying the brain among patients being treated with the asthma drug omalizumab ( Xolair , Genentech ) than in those who were not treated ... [Published Formulary Journal - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

Patient access to orphan drugs faces new set of challenges

In 1983, the United States enacted the Orphan Drug Act (ODA). An analogous law was passed in Europe in 2000. Both pieces of legislation are considered major successes in terms of spurring the development of orphan drugs. To illustrate, in the decade prior ... [Published Formulary Journal - Sep 29 2014]
First reported Sep 22 2014 - Updated Sep 23 2014 - 1 reports

CVS: Expansion of MinuteClinics to offset tobacco revenue loss

In an increasing effort to continue to play a complementary role with primary care practices in providing care to patients, CVS Health has worked to deplete existing cigarette inventory at CVS/pharmacy stores without receiving new shipments.CVS Caremark ... [Published Formulary Journal - Sep 22 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Revitalizing stagnant sepsis pipeline requires targeting niche patient populations, with premium pricing likely justified

HanselAlthough the growing public outcry surrounding antibiotic resistance has only recently propelled sepsis back into the international spotlight, in reality, the sepsis marketplace has been one of high unmet medical need for decades. The condition, ... [Published Formulary Journal - Sep 22 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

[BLOG]: Medications are the new battlefield and pharmacists are the best “recon” agents

Medication-related problems (MRPs) can be a significant patient safety risk, particularly in hospitalized patients. One method used to minimize this safety concern is through medication reconciliation, or the process of documentation of a patient’s outpatient ... [Published Formulary Journal - Sep 15 2014]

Quotes

...according to FormularyWatch advisor James M Wooten, PharmD, associate professor, department of medicine, University of Missouri-Kansas City. "It will take some time to sort through the data to assess efficacy of a product like this. My guess is that there several other pharmaceutical companies that may also bring products to market for evaluation."

More Content

All (12) | News (12) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Flu vaccine: What you need to know [Published Formulary Journal - 8 hours ago]
Dallas Ebola victim dies; received experimental... [Published Formulary Journal - Oct 08 2014]
Specialty drugs: A good value, despite high costs [Published Formulary Journal - Oct 08 2014]
Metformin linked to low levels of thyroid-stimu... [Published Formulary Journal - Oct 08 2014]
Bristol-Myers Squibb withdraws potential hep C ... [Published Formulary Journal - Oct 08 2014]
Cost, use of opioid dependence treatment are in... [Published Formulary Journal - Oct 07 2014]
Study to measure impact of MTM on outcomes for ... [Published Formulary Journal - Oct 03 2014]
FDA: Slightly elevated risk of cardiovascular, ... [Published Formulary Journal - Sep 29 2014]
Patient access to orphan drugs faces new set of... [Published Formulary Journal - Sep 29 2014]
CVS: Expansion of MinuteClinics to offset tobac... [Published Formulary Journal - Sep 22 2014]
Revitalizing stagnant sepsis pipeline requires ... [Published Formulary Journal - Sep 22 2014]
[BLOG]: Medications are the new battlefield and... [Published Formulary Journal - Sep 15 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.